使用多重蛋白质组学方法识别PD的诊断和预后生物标志物
Jodi Maple-Grødem1, Anastasia Ushakova2, Kenn Freddy Pedersen3
1Centre for Movement Disorders, Centre for Brain Health, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.
Neurobiology of disease
|September 6, 2023
概括
帕金森病 (PD) 诊断可能会通过新的生物标志物得到改善. 研究人员发现,在PD患者中,四种蛋白质 (β-NGF,CD38,tau,NCAN) 的调节下降,较高的tau与更快的认知衰退有关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 帕金森病 (PD) 的诊断和预后非常复杂.
- 生物标志物面板对于提高PD诊断和预后准确度至关重要.
研究的目的:
- 确定脑脊液 (CSF) 中的新型蛋白质生物标志物,用于早期诊断和预后帕金森病.
- 调查特定蛋白质与新诊断的PD患者认知衰退的关联.
主要方法:
- 利用近距离扩展试验 (PEA) 来分析CSF中的92种蛋白质组.
- 包括120名新诊断的PD患者和45名健康对照.
- 应用调节回归分析来识别差异表达蛋白质及其与认知衰退的相关性.
主要成果:
- 与对照组相比,新诊断的PD患者的CSF中发现了四种下调蛋白 (β-NGF,CD38,tau和NCAN).
- 在诊断后的第一个十年里,较高的陶蛋白水平与更快的认知衰退显著相关.
- 这些蛋白质在90%以上的受试者中被检测到.
结论:
- 鉴定出的蛋白质面板为改善帕金森病的诊断和预后准确性提供了潜力.
- 研究结果提供了对PD病理生理学的见解,并提出了新的治疗点.
- 蛋白可能作为PD认知衰退的预后生物标志物.
相关概念视频
Proteomics
7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593


